International Journal of Radiation Oncology*Biology*Physics: Volume 106 (Issue 1 to Issue 5)
Journal Spotlight: International Journal of Radiation Oncology – Biology – Physics (IJROBP)
The International Journal of Radiation Oncology – Biology – Physics (IJROBP), affectionately known as the Red Journal, is a prestigious publication that serves as a vital resource for the field of radiation oncology. This journal is affiliated with the American Society for Radiation Oncology (ASTRO) and focuses on the publication of original laboratory and clinical investigations related to several key areas:
- Radiation Oncology: IJROBP welcomes contributions related to prospective clinical trials, outcomes research, and large database analysis. It provides a platform for researchers to share their findings related to the clinical applications of radiation therapy.
- Radiation Biology: The journal also explores the fundamental aspects of radiation biology, including studies on tumor physiology, molecular biology underlying cancer, and the response of normal tissues to radiation. These insights are crucial for advancing our understanding of the effects of radiation on the human body.
- Medical Physics: IJROBP features technical advances in the field of medical physics, with a focus on dosimetry and conformal radiation treatment planning. These contributions help shape the technological aspects of radiation therapy.
- Education and Health Policy: The journal is committed to promoting education and facilitating discussions on health policy as it relates to radiation oncology. These topics have a direct impact on the practice of radiation therapy.
The Red Journal is particularly interested in original contributions, prospective clinical trials, outcomes research, and high-impact innovations in various aspects of radiation therapy, including single or combined modality treatment, tumor sensitization, normal tissue protection, brachytherapy, particle irradiation, and cancer imaging. It also encourages investigations into precision avoidance and pharmacologic approaches for normal tissue protection.
As an authoritative voice in the field, the journal provides a platform for researchers, clinicians, and experts in radiation oncology to share their findings, engage in discussions, and contribute to the advancement of patient care and scientific knowledge.
IJROBP is an essential resource for anyone involved in the practice and study of radiation oncology. It plays a vital role in disseminating the latest research and innovations, helping to improve the care and treatment of patients.
Volume 106, Issue 1: Pages A1-A16, e1-e4, 1-224 (1 January 2020)
Volume 106, Issue 2: Pages A1-A14, 225-454 (1 February 2020)
Volume 106, Issue 3: Pages A1-A18, 455-652 (1 March 2020)
Volume 106, Issue 4: Pages A1-A12, 653-892 (15 March 2020)
Volume 106, Issue 5: Pages A1-A20, 893-1228 (1 April 2020)
Reviews
There are no reviews yet.